Page 1 of Clinical Trials for Drug Tiotropium Salmeterol QD, 21 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol PE Capsule) in COPD
Last Updated: July 13, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
2
Terminated
Tiotropium/Salmeterol Inhalation Powder in COPD
Last Updated: July 14, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
3
Completed
Tiotropium and Salmeterol PK Study in COPD Patients
Last Updated: July 22, 2009
Condition(s): Pulmonary Disease, Chronic Obstructive
4
Completed
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Last Updated: May 18, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
5
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Last Updated: May 11, 2012
Condition(s): Asthma
6
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Last Updated: May 11, 2012
Condition(s): Asthma
7
Recruiting
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: May 11, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
8
Completed
Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: January 19, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
9
Completed
Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg
Last Updated: May 18, 2012
Condition(s): Asthma
10
Completed
Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD
Last Updated: October 12, 2009
Condition(s): Pulmonary Disease, Chronic Obstructive
11
Completed
Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD
Last Updated: May 18, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
12
Completed
Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD
Last Updated: May 28, 2009
Condition(s): Pulmonary Disease, Chronic Obstructive
13
Completed
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim
Last Updated: May 17, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
14
Completed
A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: May 14, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
15
Completed
A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
Last Updated: May 11, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
16
Recruiting
Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)
Last Updated: March 11, 2012
Condition(s): Asthma
17
Completed
SERETIDE Plus Tiotropium Versus Individual Components
Last Updated: June 19, 2007
Condition(s): Chronic Obstructive Pulmonary Disease
18
Not yet recruiting
Acute and Chronic Effects of an Anticholinergic Agent or a Long-Acting Beta 2 Agonist on Levels of Exhaled Nitric Oxide and Pulmonary Function in Persons With Tetraplegia
Last Updated: May 17, 2011
Condition(s): Spinal Cord Injury
19
Recruiting
Tiotropium for Smoking Asthmatics Study
Last Updated: July 12, 2011
Condition(s): Asthma
20
Completed
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: December 16, 2010
Condition(s): CV Risk; Pulmonary Disease, Chronic Obstructive; Chronic Bronchitis; Chronic Obstructive Pulmonary Disease (COPD); Cardiovascular Disease; Smoking; Emphysema

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Tiotropium+Salmeterol+QD

Page 1 of Clinical Trials for Drug Tiotropium Salmeterol QD, 21 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About